CardiAQ Valve Technologies Secures $37,300,000 Series B Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b73d90da-e4b6-4d86-b5ab-cf0644575a00&Preview=1
Date
11/29/2012
Company Name
CardiAQ Valve Technologies
Mailing Address
2 Jenner Irvine, CA 92618
Company Description
CardiAQ Valve Technologies (CVT), a privately held company founded by heart surgeon Dr. Arshad Quadri, is developing innovative approaches to heart valve replacement and is initially focused on percutaneous mitral valve replacement (PMVR).
Website
http://www.cardiaq.com
Transaction Type
Venture Equity
Transaction Amount
$37,300,000
Transaction Round
Series B
Proceeds Purposes
The funding, which incorporates conversion of a 2011 bridge financing, will be used to further validate the Company’s TMVI technology and is expected to carry the Company through its feasibility and CE mark clinical trials.
M&A Terms
Venture Investor
OrbiMed Advisors
Venture Investor
OrbiMed Advisors
Venture Investor
Versant Ventures
Venture Investor
Advent Healthcare Ventures